SK
Skinvisible, Inc.
SKVI · OTC
$0.20 +0.00% (+$0.00)
1M +139.78%
Market Cap $1.09M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.24
19.4% upside
Current Price
$0.2
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SKVI is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/S 54.31x
EV/EBITDA N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 58.47%
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Net margin 5,156.59%
Op. margin 2,294.91%
FCF margin 192,050,000.00%
Quality
32 /100
Poor ROA 836.20%
Asset turnover 0.16x
ROIC 9.07%
Debt
0 /100
High Int. coverage -0.80x
Current ratio 0.01x
Net debt/EBITDA N/A
Stability
5 /100
Unstable Rev. volatility 53.60%
EPS volatility 80.38%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SKVI
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Terry H. Howlett
Employees
2
Headquarters
Las Vegas